170 related articles for article (PubMed ID: 30389152)
1. Therapeutic research in the crystal chromosome disease Fanconi anemia.
Minguillón J; Surrallés J
Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt A):104-108. PubMed ID: 30389152
[TBL] [Abstract][Full Text] [Related]
2. Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics.
Bogliolo M; Surrallés J
Curr Opin Genet Dev; 2015 Aug; 33():32-40. PubMed ID: 26254775
[TBL] [Abstract][Full Text] [Related]
3. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
Hanenberg H; Roellecke K; Wiek C
Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
[TBL] [Abstract][Full Text] [Related]
4. Fanconi Anemia: Overview of the Disease and the Role of Hematopoietic Transplantation.
Schifferli A; Kühne T
J Pediatr Hematol Oncol; 2015 Jul; 37(5):335-43. PubMed ID: 26086276
[TBL] [Abstract][Full Text] [Related]
5. Finding the needle in the hay stack: hematopoietic stem cells in Fanconi anemia.
Müller LU; Williams DA
Mutat Res; 2009 Jul; 668(1-2):141-9. PubMed ID: 19508850
[TBL] [Abstract][Full Text] [Related]
6. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
[TBL] [Abstract][Full Text] [Related]
7. Advances in Gene Therapy for Fanconi Anemia.
Río P; Navarro S; Bueren JA
Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
[TBL] [Abstract][Full Text] [Related]
8. Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia.
Adair JE; Sevilla J; Heredia CD; Becker PS; Kiem HP; Bueren J
Curr Gene Ther; 2017; 16(5):338-348. PubMed ID: 28103787
[TBL] [Abstract][Full Text] [Related]
9. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.
Río P; Navarro S; Wang W; Sánchez-Domínguez R; Pujol RM; Segovia JC; Bogliolo M; Merino E; Wu N; Salgado R; Lamana ML; Yañez RM; Casado JA; Giménez Y; Román-Rodríguez FJ; Álvarez L; Alberquilla O; Raimbault A; Guenechea G; Lozano ML; Cerrato L; Hernando M; Gálvez E; Hladun R; Giralt I; Barquinero J; Galy A; García de Andoín N; López R; Catalá A; Schwartz JD; Surrallés J; Soulier J; Schmidt M; Díaz de Heredia C; Sevilla J; Bueren JA
Nat Med; 2019 Sep; 25(9):1396-1401. PubMed ID: 31501599
[TBL] [Abstract][Full Text] [Related]
10. Current clinical management of Fanconi anemia.
Smith AR; Wagner JE
Expert Rev Hematol; 2012 Oct; 5(5):513-22. PubMed ID: 23146055
[TBL] [Abstract][Full Text] [Related]
11. Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients.
Ramírez MJ; Pujol R; Trujillo-Quintero JP; Minguillón J; Bogliolo M; Río P; Navarro S; Casado JA; Badell I; Carrasco E; Balmaña J; Català A; Sevilla J; Beléndez C; Argilés B; López M; Díaz de Heredia C; Rao G; Nicoletti E; Schwartz JD; Bueren JA; Surrallés J
Am J Hematol; 2021 Aug; 96(8):989-999. PubMed ID: 33984160
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis on phenotype and genetic basis of Chinese Fanconi anemia patients: dismal outcomes call for nationwide studies.
Nie D; Zhang J; Wang F; Zhang W; Liu L; Chen X; Zhang Y; Cao P; Xiong M; Wang T; Wu P; Ma X; Tian W; Wang M; Chen KN; Liu H
BMC Med Genet; 2020 Jun; 21(1):118. PubMed ID: 32487094
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic Stem Cell Transplant in Adolescent and Young Adults With Fanconi Anemia Is Feasible With Acceptable Toxicity, With Those Surviving 100 Days Posttransplant Having Excellent Outcomes.
Alhuraiji A; Alzahrani H; Al Mohareb F; Chaudhri N; Alsharif F; Mohamed S; Rasheed W; Aldawsari G; Ahmed SO; Aljurf M
Exp Clin Transplant; 2016 Dec; 14(6):660-664. PubMed ID: 27447289
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy in the treatment of Fanconi anemia, a progressive bone marrow failure syndrome.
Williams DA; Croop J; Kelly P
Curr Opin Mol Ther; 2005 Oct; 7(5):461-6. PubMed ID: 16248281
[TBL] [Abstract][Full Text] [Related]
15. Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.
Nicoletti E; Rao G; Bueren JA; Río P; Navarro S; Surrallés J; Choi G; Schwartz JD
Ann Hematol; 2020 May; 99(5):913-924. PubMed ID: 32065290
[TBL] [Abstract][Full Text] [Related]
16. LNK (SH2B3) inhibition expands healthy and Fanconi anemia human hematopoietic stem and progenitor cells.
Holdreith N; Lee G; Chandra V; Salinas CS; Nicholas P; Olson TS; Tong W
Blood Adv; 2022 Feb; 6(3):731-745. PubMed ID: 34844262
[TBL] [Abstract][Full Text] [Related]
17. Management of Fanconi anemia beyond childhood.
Olson TS
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):556-562. PubMed ID: 38066849
[TBL] [Abstract][Full Text] [Related]
18. Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia.
Chao MM; Ebell W; Bader P; Beier R; Burkhardt B; Feuchtinger T; Handgretinger R; Hanenberg H; Koehl U; Kratz C; Kremens B; Lang P; Meisel R; Mueller I; Roessig C; Sauer M; Schlegel PG; Schulz A; Strahm B; Thol F; Sykora KW
Klin Padiatr; 2015 May; 227(3):157-65. PubMed ID: 25985449
[TBL] [Abstract][Full Text] [Related]
19. HSCT for Fanconi anemia in children: factors that influence early and late results.
Dalle JH
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S51-3. PubMed ID: 18978745
[TBL] [Abstract][Full Text] [Related]
20. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.
Rosenberg PS; Alter BP; Ebell W
Haematologica; 2008 Apr; 93(4):511-7. PubMed ID: 18322251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
